Healthcare

Uterine Manipulation Devices Market Size to Rake US$ 473.81 Mn by 2030

The global Uterine Manipulation Devices market size is expected to be worth around US$ 473.81 Mn by 2030, according to a new report by Vision Research Reports.

Uterine Manipulation Devices Market (By Application: Total Laparoscopy Hysterectomy (TLH), Laparoscopic Supracervical Hysterectomy (LSH), Laparoscopically Assisted Vaginal Hysterectomy (LAVH),Sacrocolpopexy, Other Applications; By End-use: Hospitals, Clinics, Ambulatory Surgery Centers (ASCs)) – Global Industry Analysis, Size, Share, Growth, Trends, Revenue, Regional Outlook 2021 – 2030

Get Sample Copy of This Report@ https://www.visionresearchreports.com/report/sample/38306

Report Highlights

the hospitals segment dominated the market with a share of 59.15%. The growth of this segment can mainly be attributed to an increase in the number of patients suffering from various gynecological conditions and a consequent rise in the number of surgical procedures. Hospitals offer superior care to patients and provide reimbursements for certain procedures, which is further contributing to the segment growth. Furthermore, hospitals are currently advancing in terms of technology. Technologically advanced devices are being used extensively in hospitals to provide better treatment. These devices are not only simplifying treatment procedures but also providing better, faster, and accurate results.

The lower risk of post-surgical complications in minimally invasive laparoscopic surgery is expected to increase the demand for ambulatory surgery centers. They offer several advantages to patients including shorter procedure time and same-day discharge as compared to hospitals. Most intra-abdominal procedures can now be performed laparoscopically at ambulatory surgery centers as these are less invasive. Surgeries at ambulatory surgery centers not only have shorter stay duration but are also more affordable than inpatient procedures, which reduces patient expenditure. Thus, owing to the abovementioned factors, the ambulatory surgery centers segment is likely to witness rapid growth during the forecast period.

North America dominated the market with a share of 45.67% in 2020 and is expected to witness considerable growth over the forecast period. This is owing to the increasing number of gynecology-related surgical procedures/hospital visits, the presence of well-established healthcare infrastructure, favorable reimbursement policies, and supportive regulatory reforms in the healthcare sector. According to CMS, healthcare spending in the U.S. increased by 5.6% and reached USD 4.8 trillion in 2019, accounting for approximately 27.7% of GDP. The national health spending is expected to grow at an annual rate of 10.4% from 2019 to 2030, to reach USD 6.2 trillion by the year 2028. The ease of access to healthcare technologies and the presence of strong distribution channels are also driving the adoption of uterine manipulation devices in the region.

Key Players

  • Conkin Surgical Instruments Ltd.
  • Johnson and Johnson
  • CooperSurgical, Inc.
  • B. Braun Medical Ltd.
  • KARL STORZ GmbH & Co. KG
  • CONMED Corporation
  • RUDOLF Medical GmbH + Co. KG
  • LiNA Medical ApS
  • Richard Wolf GmbH
  • Utah Medical Products, Inc.
  • Purple Surgical
  • Clinical Innovations, LLC
  • Bissinger Medizintechnik
  • The O.R. Company (Symmetry Surgical Inc.)
  • LSI Solutions, Inc.

Market Segmentation

  • Application Outlook
    • Total Laparoscopy Hysterectomy (TLH)
    • Laparoscopic Supracervical Hysterectomy (LSH)
    • Laparoscopically Assisted Vaginal Hysterectomy (LAVH)
    • Sacrocolpopexy
    • Other Applications
  • End-use Outlook
    • Hospitals
    • Clinics
    • Ambulatory Surgery Centers (ASCs)
  • Regional Outlook
    • North America
      • U.S.
      • Canada
    • Europe
      • Germany
      • U.K.
      • France
      • Italy
      • Spain
      • Norway
      • Sweden
      • Russia
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • South Korea
    • Latin America
      • Brazil
      • Mexico
      • Argentina
      • Colombia
    • Middle East & Africa
      • South Africa
      • Saudi Arabia
      • UAE
      • Turkey
      • Qatar

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38306

Table of Contents

Chapter 1.  Introduction

1.1.  Research Objective

1.2.  Scope of the Study

1.3.  Definition

Chapter 2.  Research Methodology

2.1.  Research Approach

2.2.  Data Sources

2.3.  Assumptions & Limitations

Chapter 3.  Executive Summary

3.1.  Market Snapshot

Chapter 4.  Market Variables and Scope

4.1.  Introduction

4.2.  Market Classification and Scope

4.3.  Industry Value Chain Analysis

4.3.1.    Raw Material Procurement Analysis

4.3.2.    Sales and Distribution Channel Analysis

4.3.3.    Downstream Buyer Analysis

Chapter 5.  Market Dynamics Analysis and Trends

5.1.  Market Dynamics

5.1.1.    Market Drivers

5.1.2.    Market Restraints

5.1.3.    Market Opportunities

5.2.  Porter’s Five Forces Analysis

5.2.1.    Bargaining power of suppliers

5.2.2.    Bargaining power of buyers

5.2.3.    Threat of substitute

5.2.4.    Threat of new entrants

5.2.5.    Degree of competition

Chapter 6.  Competitive Landscape

6.1.1.    Company Market Share/Positioning Analysis

6.1.2.    Key Strategies Adopted by Players

6.1.3.    Vendor Landscape

6.1.3.1.        List of Suppliers

6.1.3.2.        List of Buyers

Chapter 7.  Global Uterine Manipulation Devices Market, By Application

7.1.  Uterine Manipulation Devices Market, by Application, 2021-2030

7.1.1.    Total Laparoscopy Hysterectomy (TLH)

7.1.1.1.        Market Revenue and Forecast (2016-2030)

7.1.2.    Laparoscopic Supracervical Hysterectomy (LSH)

7.1.2.1.        Market Revenue and Forecast (2016-2030)

7.1.3.    Laparoscopically Assisted Vaginal Hysterectomy (LAVH)

7.1.3.1.        Market Revenue and Forecast (2016-2030)

7.1.4.    Sacrocolpopexy

7.1.4.1.        Market Revenue and Forecast (2016-2030)

7.1.5.    Other Applications

7.1.5.1.        Market Revenue and Forecast (2016-2030)

Chapter 8.  Global Uterine Manipulation Devices Market, By End-use

8.1.  Uterine Manipulation Devices Market, by End-use, 2021-2030

8.1.1.    Hospitals

8.1.1.1.        Market Revenue and Forecast (2016-2030)

8.1.2.    Clinics

8.1.2.1.        Market Revenue and Forecast (2016-2030)

8.1.3.    Ambulatory Surgery Centers (ASCs)

8.1.3.1.        Market Revenue and Forecast (2016-2030)

Chapter 9.  Global Uterine Manipulation Devices Market, Regional Estimates and Trend Forecast

9.1.  North America

9.1.1.    Market Revenue and Forecast, by Application (2016-2030)

9.1.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.1.3.    U.S.

9.1.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.1.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.1.4.    Rest of North America

9.1.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.1.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.  Europe

9.2.1.    Market Revenue and Forecast, by Application (2016-2030)

9.2.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.2.3.    UK

9.2.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.2.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.4.    Germany

9.2.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.2.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.5.    France

9.2.5.1.        Market Revenue and Forecast, by Application (2016-2030)

9.2.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.2.6.    Rest of Europe

9.2.6.1.        Market Revenue and Forecast, by Application (2016-2030)

9.2.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.  APAC

9.3.1.    Market Revenue and Forecast, by Application (2016-2030)

9.3.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.3.3.    India

9.3.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.3.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.4.    China

9.3.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.3.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.5.    Japan

9.3.5.1.        Market Revenue and Forecast, by Application (2016-2030)

9.3.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.3.6.    Rest of APAC

9.3.6.1.        Market Revenue and Forecast, by Application (2016-2030)

9.3.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.  MEA

9.4.1.    Market Revenue and Forecast, by Application (2016-2030)

9.4.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.4.3.    GCC

9.4.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.4.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.4.    North Africa

9.4.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.4.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.5.    South Africa

9.4.5.1.        Market Revenue and Forecast, by Application (2016-2030)

9.4.5.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.4.6.    Rest of MEA

9.4.6.1.        Market Revenue and Forecast, by Application (2016-2030)

9.4.6.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.5.  Latin America

9.5.1.    Market Revenue and Forecast, by Application (2016-2030)

9.5.2.    Market Revenue and Forecast, by End-use (2016-2030)

9.5.3.    Brazil

9.5.3.1.        Market Revenue and Forecast, by Application (2016-2030)

9.5.3.2.        Market Revenue and Forecast, by End-use (2016-2030)

9.5.4.    Rest of LATAM

9.5.4.1.        Market Revenue and Forecast, by Application (2016-2030)

9.5.4.2.        Market Revenue and Forecast, by End-use (2016-2030)

Chapter 10.  Company Profiles

10.1.              Conkin Surgical Instruments Ltd.

10.1.1.  Company Overview

10.1.2.  Product Offerings

10.1.3.  Financial Performance

10.1.4.  Recent Initiatives

10.2.              Johnson and Johnson

10.2.1.  Company Overview

10.2.2.  Product Offerings

10.2.3.  Financial Performance

10.2.4.  Recent Initiatives

10.3.              CooperSurgical, Inc.

10.3.1.  Company Overview

10.3.2.  Product Offerings

10.3.3.  Financial Performance

10.3.4.  Recent Initiatives

10.4.              B. Braun Medical Ltd.

10.4.1.  Company Overview

10.4.2.  Product Offerings

10.4.3.  Financial Performance

10.4.4.  Recent Initiatives

10.5.              KARL STORZ GmbH & Co. KG

10.5.1.  Company Overview

10.5.2.  Product Offerings

10.5.3.  Financial Performance

10.5.4.  Recent Initiatives

10.6.              CONMED Corporation

10.6.1.  Company Overview

10.6.2.  Product Offerings

10.6.3.  Financial Performance

10.6.4.  Recent Initiatives

10.7.              RUDOLF Medical GmbH + Co. KG

10.7.1.  Company Overview

10.7.2.  Product Offerings

10.7.3.  Financial Performance

10.7.4.  Recent Initiatives

10.8.              LiNA Medical ApS

10.8.1.  Company Overview

10.8.2.  Product Offerings

10.8.3.  Financial Performance

10.8.4.  Recent Initiatives

10.9.              Richard Wolf GmbH

10.9.1.  Company Overview

10.9.2.  Product Offerings

10.9.3.  Financial Performance

10.9.4.  Recent Initiatives

10.10.           Utah Medical Products, Inc.

10.10.1.               Company Overview

10.10.2.               Product Offerings

10.10.3.               Financial Performance

10.10.4.               Recent Initiatives

10.11.           Purple Surgical

10.11.1.               Company Overview

10.11.2.               Product Offerings

10.11.3.               Financial Performance

10.11.4.               Recent Initiatives

10.12.           Clinical Innovations, LLC

10.12.1.               Company Overview

10.12.2.               Product Offerings

10.12.3.               Financial Performance

10.12.4.               Recent Initiatives

10.13.           Bissinger Medizintechnik

10.13.1.               Company Overview

10.13.2.               Product Offerings

10.13.3.               Financial Performance

10.13.4.               Recent Initiatives

10.14.           The O.R. Company (Symmetry Surgical Inc.)

10.14.1.               Company Overview

10.14.2.               Product Offerings

10.14.3.               Financial Performance

10.14.4.               Recent Initiatives

10.15.           LSI Solutions, Inc.

10.15.1.               Company Overview

10.15.2.               Product Offerings

10.15.3.               Financial Performance

10.15.4.               Recent Initiatives

Chapter 11.  Research Methodology

11.1.              Primary Research

11.2.              Secondary Research

11.3.              Assumptions

Chapter 12.  Appendix

12.1.              About Us

Glossary of Terms

Buy This Report, click here@ https://www.visionresearchreports.com/report/cart/38306

About Us: Our team of skilled and experienced analysts specializes in troubleshooting problems faced by our clients. For comprehensive summary of our services and market research requirements for Global industry.

Contact Us:

call: +1 9197 992 333

Vision Research Report

Any Assistance, Email – sales@visionresearchreports.com

Show More

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

Related Articles

Back to top button